Sharing CD4+ T Cell Loss: When COVID-19 and HIV Collide on Immune System.
Front Immunol
; 11: 596631, 2020.
Artigo
em Inglês
| MEDLINE | ID: covidwho-1004678
ABSTRACT
COVID-19 is a distinctive infection characterized by elevated inter-human transmission and presenting from absence of symptoms to severe cytokine storm that can lead to dismal prognosis. Like for HIV, lymphopenia and drastic reduction of CD4+ T cell counts in COVID-19 patients have been linked with poor clinical outcome. As CD4+ T cells play a critical role in orchestrating responses against viral infections, important lessons can be drawn by comparing T cell response in COVID-19 and in HIV infection and by studying HIV-infected patients who became infected by SARS-CoV-2. We critically reviewed host characteristics and hyper-inflammatory response in these two viral infections to have a better insight on the large difference in clinical outcome in persons being infected by SARS-CoV-2. The better understanding of mechanism of T cell dysfunction will contribute to the development of targeted therapy against severe COVID-19 and will help to rationally design vaccine involving T cell response for the long-term control of viral infection.
Palavras-chave
Texto completo:
Disponível
Coleções:
Bases de dados internacionais
Base de dados:
MEDLINE
Assunto principal:
Linfócitos T CD4-Positivos
/
Infecções por HIV
/
SARS-CoV-2
/
COVID-19
/
Linfopenia
Tipo de estudo:
Estudo prognóstico
Tópicos:
Covid persistente
/
Vacinas
Limite:
Humanos
Idioma:
Inglês
Revista:
Front Immunol
Ano de publicação:
2020
Tipo de documento:
Artigo
País de afiliação:
Fimmu.2020.596631
Similares
MEDLINE
...
LILACS
LIS